Tanguy Y Seiwert

18PUBLICATIONS
128CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy.

Howard L Li, Soren Charmsaz, Mari Nakazawa

|Apr 29, 2025
INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Jérôme Fayette, Lisa Licitra, Kevin Harrington

|Jan 20, 2025
Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade.

Stephanie L Alden, Soren Charmsaz, Howard L Li

|Sep 09, 2024
Lower survival for surgical treatment of human papillomavirus-related oropharynx cancer at community cancer centers.

Danielle R Trakimas, Wojciech K Mydlarz, Leila J Mady

|Apr 11, 2023
Complete response to alectinib in ALK-fusion metastatic salivary ductal carcinoma.

Jacob J Adashek, Surendra Sapkota, Rodrigo de Castro Luna

Pageof 3